- Supported exchanges /
- SHE /
- 301089.SHE
Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089 SHE) stock market data APIs
Tuoxin Pharmaceutical Group Co.,Ltd. engages in the research, development, production, and sale of chemical synthesis, biological fermentation nucleoside (acid) APIs, and pharmaceutical intermediates in China and internationally. It offers purine base, pyrimidine base, nucleosides, nucleotide, deoxynucleosides, dehyfrated nucleoside, 2'-modified, Cybinucleoside, and sugar series, and Azvudine intermediate. The company also provides Disodium 5'-cytidylate, Disodium 5'-uridylate, 5'-Adenosine monophosphate, and D-ribose, as well as citicoline sodium, ribavir Lin, inosine, acyclovir, cytosine, 5-fluorocytosine, cytidine, and other APIs and pharmaceutical intermediates. The company was founded in 2001 and is based in Xinxiang, China.
Xinxiang Tuoxin Pharmaceutical Co.Ltd. Financial Data Overview
| 32.13 | |
| 31.61 | |
| - | |
| 32.3 | |
| 31.48 | |
| 25.95-61.5984 | |
| 3 991 M | |
| 127 M | |
| 415 M | |
| -0.0069 | |
| 0.0079 | |
| -0.889 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Xinxiang Tuoxin Pharmaceutical Co.Ltd. Fundamental Data is available in our Financial Data APIs
- Net Revenue 415 M
- EBITDA -48 731 720
- Earnings Per Share -0.58
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Xinxiang Tuoxin Pharmaceutical Co.Ltd. Earnings via APIs
- Latest Release 2024-09-30
- EPS/Forecast NaN
Get Xinxiang Tuoxin Pharmaceutical Co.Ltd. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
